IL132651A0 - Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity - Google Patents

Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity

Info

Publication number
IL132651A0
IL132651A0 IL13265198A IL13265198A IL132651A0 IL 132651 A0 IL132651 A0 IL 132651A0 IL 13265198 A IL13265198 A IL 13265198A IL 13265198 A IL13265198 A IL 13265198A IL 132651 A0 IL132651 A0 IL 132651A0
Authority
IL
Israel
Prior art keywords
antiviral
acitvity
pharmaceutical
glycyrrhizic acid
composition
Prior art date
Application number
IL13265198A
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of IL132651A0 publication Critical patent/IL132651A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13265198A 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity IL132651A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001119A IT1291366B1 (en) 1997-05-14 1997-05-14 ANTIVIRAL PHARMACEUTICAL COMPOSITION INCLUDING GLYCYRHIZIC ACID AND AT LEAST ONE PROTEIN WITH ANTIVIRAL ACTIVITY
PCT/EP1998/002797 WO1998051334A1 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity

Publications (1)

Publication Number Publication Date
IL132651A0 true IL132651A0 (en) 2001-03-19

Family

ID=11377123

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13265198A IL132651A0 (en) 1997-05-14 1998-05-06 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity
IL132651A IL132651A (en) 1997-05-14 1999-10-29 Pharmaceutical antiviral composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL132651A IL132651A (en) 1997-05-14 1999-10-29 Pharmaceutical antiviral composition

Country Status (27)

Country Link
US (1) US6329339B1 (en)
EP (1) EP0980254B1 (en)
JP (2) JP2001525814A (en)
KR (1) KR100592193B1 (en)
CN (1) CN1114447C (en)
AR (1) AR012849A1 (en)
AT (1) ATE212232T1 (en)
AU (1) AU740944B2 (en)
BG (1) BG64748B1 (en)
CA (1) CA2289550A1 (en)
CZ (1) CZ291932B6 (en)
DE (1) DE69803565T2 (en)
DK (1) DK0980254T3 (en)
EA (1) EA003126B1 (en)
ES (1) ES2170501T3 (en)
GE (1) GEP20022672B (en)
HK (1) HK1028347A1 (en)
HU (1) HU224956B1 (en)
IL (2) IL132651A0 (en)
IT (1) IT1291366B1 (en)
PL (1) PL189218B1 (en)
PT (1) PT980254E (en)
SK (1) SK283584B6 (en)
TR (1) TR199902730T2 (en)
UA (1) UA63955C2 (en)
WO (1) WO1998051334A1 (en)
ZA (1) ZA983917B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7151082B2 (en) * 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US7304034B2 (en) * 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
EP1499341A4 (en) * 2002-04-18 2010-10-27 Univ Iowa Res Found Methods of inhibiting and treating bacterial biofilms by metal chelators
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2538763C (en) * 2003-09-11 2015-05-05 Critical Therapeutics, Inc. Monoclonal antibodies against hmgb1
EP1909834A2 (en) * 2005-07-18 2008-04-16 Critical Therapeutics, Inc. Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
AU2006330807A1 (en) * 2005-11-28 2007-07-05 Medimmune, Llc Antagonists of HMBG1 and/or rage and methods of use thereof
IT1391170B1 (en) * 2008-08-07 2011-11-18 D M G Italia S R L INTRA-NASAL TOPIC COMPOSITION USABLE IN CASE OF NASAL OBSTRUCTION
WO2012026928A1 (en) * 2010-08-25 2012-03-01 Diacarta Llc Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US9416151B2 (en) 2010-08-25 2016-08-16 Lurong ZHANG Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis
US20170049863A1 (en) * 2014-02-21 2017-02-23 National University Corporation Tokyo University Of Marine Science And Technology Norovirus deactivator and method for producing same, method for deactivating norovirus, method for producing lysozyme component for norovirus deactivation use, prophylactic or therapeutic agent for norovirus infection, and external preparation for skin for norovirus deactivation purposes
WO2017147540A1 (en) * 2016-02-25 2017-08-31 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
CN109022351B (en) * 2018-09-28 2021-10-19 广州奇龙生物科技有限公司 New application of recombinant human lysozyme
CN112805027B (en) * 2020-04-27 2023-10-10 广州新创忆药物临床研究有限公司 Medicine for resisting new coronavirus infection and application
US20220305092A1 (en) * 2020-04-27 2022-09-29 Guangzhou Century Clinical Research Co., Ltd Medicament and food for preventing or treating novel coronavirus pneumonia covid-19 and use thereof
CN112135625B (en) * 2020-04-27 2021-07-06 广州新创忆药物临床研究有限公司 Medicine for preventing or treating COVID-19 new coronary pneumonia and application thereof
MX2021005280A (en) 2021-05-04 2022-02-23 Spv Timser S A P I De C V Pharmaceutical composition containing pentacyclic triterpenoids.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085800B2 (en) * 1986-12-19 1996-01-24 エーザイ株式会社 Aqueous formulation containing lysozyme chloride and dipotassium glycyrrhizinate
JP2838720B2 (en) * 1989-10-31 1998-12-16 ゼリア新薬工業株式会社 Stable eye drops
JP4056099B2 (en) * 1996-05-09 2008-03-05 森永乳業株式会社 Preventive and therapeutic agents for parasitic diseases in aquatic animals

Also Published As

Publication number Publication date
HK1028347A1 (en) 2001-02-16
HUP0002985A2 (en) 2001-01-29
WO1998051334A1 (en) 1998-11-19
US6329339B1 (en) 2001-12-11
EA003126B1 (en) 2003-02-27
CZ399199A3 (en) 2000-04-12
ES2170501T3 (en) 2002-08-01
KR20010012419A (en) 2001-02-15
JP2001525814A (en) 2001-12-11
TR199902730T2 (en) 2000-02-21
EA199901024A1 (en) 2000-06-26
UA63955C2 (en) 2004-02-16
BG64748B1 (en) 2006-02-28
IT1291366B1 (en) 1999-01-07
KR100592193B1 (en) 2006-06-23
HUP0002985A3 (en) 2001-04-28
JP2009102370A (en) 2009-05-14
GEP20022672B (en) 2002-04-25
DK0980254T3 (en) 2002-05-06
ITMI971119A0 (en) 1997-05-14
CN1114447C (en) 2003-07-16
CA2289550A1 (en) 1998-11-19
EP0980254A1 (en) 2000-02-23
AR012849A1 (en) 2000-11-22
EP0980254B1 (en) 2002-01-23
ZA983917B (en) 1998-11-09
HU224956B1 (en) 2006-04-28
IL132651A (en) 2006-10-31
DE69803565T2 (en) 2002-08-08
CN1255859A (en) 2000-06-07
SK283584B6 (en) 2003-10-07
AU7764698A (en) 1998-12-08
CZ291932B6 (en) 2003-06-18
AU740944B2 (en) 2001-11-15
DE69803565D1 (en) 2002-03-14
ATE212232T1 (en) 2002-02-15
PL336802A1 (en) 2000-07-17
PT980254E (en) 2002-07-31
PL189218B1 (en) 2005-07-29
ITMI971119A1 (en) 1998-11-14
BG103968A (en) 2000-07-31
SK154499A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
IL132651A0 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral acitvity
EP1242443A4 (en) Novel nucleic acids and polypeptides
HUP0004930A3 (en) Ampoules and manufacture thereof
EP1024130A4 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
GB9705903D0 (en) VP22 Proteins and uses thereof
AU6905698A (en) Disposable garment with extendible wings
AU8016398A (en) Peptides with antiviral activity
HUP0100192A3 (en) Improved stomach-action molluscicides and preparation thereof
CZ2000522A3 (en) Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof
ZA986756B (en) Modified polypeptides with high activity and reduced allergenicity
AU9001898A (en) Beta-fructofuranosidase and gene thereof
EP1017787A4 (en) Recombinant yeast cell and assay using same
AU1891301A (en) Novel polypeptide and dna thereof
AU8168898A (en) Interferon stimulating protein and uses thereof
AU3511100A (en) Novel nucleic acids and polypeptides
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
IL136988A0 (en) Novel nucleic acid and polypeptide
AU1821300A (en) Peptides having anti-cancer and anti-inflammatory activity
HUP0201660A2 (en) Novel polypeptide and dna thereof
EP1124840A4 (en) Ovary-specific genes and proteins
SI0980254T1 (en) Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
AU1837100A (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
IL115996A0 (en) Fluorenyl-hydroxamic derivatives endowed with immunosuppresive and anti-inflammatory activity
EP1234032A4 (en) Novel nucleic acid and polypeptide
EP1122312A4 (en) Novel protein war-1 and gene thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed